236 related articles for article (PubMed ID: 17961631)
1. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.
Houston AM; Michael-Robinson JM; Walsh MD; Cummings MC; Ryan AE; Lincoln D; Pandeya N; Jass JR; Radford-Smith GL; O'Connell J
Hum Pathol; 2008 Feb; 39(2):243-50. PubMed ID: 17961631
[TBL] [Abstract][Full Text] [Related]
2. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
3. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
4. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
5. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
[TBL] [Abstract][Full Text] [Related]
6. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma.
Smyrk TC; Watson P; Kaul K; Lynch HT
Cancer; 2001 Jun; 91(12):2417-22. PubMed ID: 11413533
[TBL] [Abstract][Full Text] [Related]
9. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
10. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
Shia J; Black D; Hummer AJ; Boyd J; Soslow RA
Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
[TBL] [Abstract][Full Text] [Related]
11. Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer.
Michael-Robinson JM; Reid LE; Purdie DM; Biemer-Hüttmann AE; Walsh MD; Pandeya N; Simms LA; Young JP; Leggett BA; Jass JR; Radford-Smith GL
Clin Cancer Res; 2001 Aug; 7(8):2347-56. PubMed ID: 11489812
[TBL] [Abstract][Full Text] [Related]
12. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
[TBL] [Abstract][Full Text] [Related]
13. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.
Modica I; Soslow RA; Black D; Tornos C; Kauff N; Shia J
Am J Surg Pathol; 2007 May; 31(5):744-51. PubMed ID: 17460459
[TBL] [Abstract][Full Text] [Related]
14. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
Ortega P; Morán A; de Juan C; Frías C; Hernández S; López-Asenjo JA; Sánchez-Pernaute A; Torres A; Iniesta P; Benito M
Clin Cancer Res; 2008 Feb; 14(4):995-1001. PubMed ID: 18281531
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
Le Gouvello S; Bastuji-Garin S; Aloulou N; Mansour H; Chaumette MT; Berrehar F; Seikour A; Charachon A; Karoui M; Leroy K; Farcet JP; Sobhani I
Gut; 2008 Jun; 57(6):772-9. PubMed ID: 17965063
[TBL] [Abstract][Full Text] [Related]
16. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
[TBL] [Abstract][Full Text] [Related]
17. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Biemer-Hüttmann A; Purdie DM; Walsh MD; Simms LA; Biden KG; Young JP; Leggett BA; Jass JR; Radford-Smith GL
Gut; 2001 Mar; 48(3):360-6. PubMed ID: 11171826
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and molecular profiles of microsatellite unstable Barrett Esophagus-associated adenocarcinoma.
Farris AB; Demicco EG; Le LP; Finberg KE; Miller J; Mandal R; Fukuoka J; Cohen C; Gaissert HA; Zukerberg LR; Lauwers GY; Iafrate AJ; Mino-Kenudson M
Am J Surg Pathol; 2011 May; 35(5):647-55. PubMed ID: 21422910
[TBL] [Abstract][Full Text] [Related]
19. [Microsatellite instability and therapeutic sensitivity].
Jung A
Verh Dtsch Ges Pathol; 2007; 91():112-8. PubMed ID: 18314604
[TBL] [Abstract][Full Text] [Related]
20. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Schwitalle Y; Kloor M; Eiermann S; Linnebacher M; Kienle P; Knaebel HP; Tariverdian M; Benner A; von Knebel Doeberitz M
Gastroenterology; 2008 Apr; 134(4):988-97. PubMed ID: 18395080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
